心臓 56/4 2024年4月号

出版社: 日本医学出版
発行日: 2024-04-15
分野: 臨床医学:内科  >  雑誌
ISSN: 05864488
雑誌名:
電子書籍版: 2024-04-15
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安:4~8営業日

2,200 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

2,200 円(税込)

目次

  • Open HEART
    心房細動診療:『早期発見・早期治療』

    HEART’s Selection
    循環器領域におけるCT新時代
    1.フォトンカウンティングCTの説明
    2.フォトンカウンティングCTを用いた冠動脈評価
    3.2層検出器dual energy CTを用いた冠動脈プラーク、冠動脈周囲脂肪、肺動脈血栓、
       心臓腫瘍、先天性心疾患の評価
    4.2層検出器dual energy CTを用いた左室、右室心筋壁、左房壁の評価
    5.Dual-energy CTを用いた尿酸塩結晶の検出
       循環器領域におけるリスク因子である高尿酸血症に対する新たなアプローチ―

    [連載]HEART’s Up To Date
    循環器医が知っておくべき最新のエビデンス
    ATTR心アミロイドーシス治療薬に関する最新の動向

    HEART’s Original
    [臨床研究]
    循環器外来患者におけるアップルウォッチの多誘導心電図記録の有用性について

    [Editorial Comment]
    辺論文に対するEditorial Comment

    [臨床研究]
    初期研修医に対して動画と簡易シミュレーターを用いた冠動脈造影指導の有効性

    [症例]
    経カテーテル大動脈弁留置術(TAVI)時のバルーン大動脈弁形成術(BAV)後に生じた
     重症大動脈弁閉鎖不全症による心原性ショックの1例

    [症例]
    アミオダロン誘因性肺障害としての肺胞出血を発症した1例

    [Editorial Comment]
    村田論文に対するEditorial Comment

    [症例]
    抗不整脈薬と抗不安薬の同時大量内服による急性薬物中毒に対しECPELLA管理が奏功した1例

    [症例]
    開心術後に持続する大量出血に対して遺伝子組換え活性型第Ⅶ因子製剤(ノボセブン®)が著効した1例

    [Editorial Comment]
    曽根論文に対するEditorial Comment

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

【HEART' s Selection】

P.328 掲載の参考文献
1) Hubbell JH, Seltzer SM:Tables of X-Ray Mass Attenuation Coefficients and Mass Energy-Absorption Coefficients 1 keV to 20 MeV for Elements Z=1 to 92 and 48 Additional Substances of Dosimetric Interest(NISTIR 5632). Gaithersburg:National Institute of Standards and Technology;1995. http://physics.nist.gov/PhysRefData/XrayMassCoef/cover.html
2) Hsieh J:Computed tomography:principles, design, artifacts, and recent advances. Bellingham:SPIE Press;2003
3) Gaddam DS, Dattwyler M, Fleiter TR, Bodanapally UK:Principles and Applications of Dual Energy Computed Tomography in Neuroradiology. Semin Ultrasound CT MR 2021;42:418-433
4) Willemink MJ, Persson M, Pourmorteza A, et al:Photon-counting CT:Technical Principles and Clinical Prospects. Radiology 2018;289:293-312
5) Wrazidlo R, Walder L, Estler A, et al:Radiation Dose Reduction in Contrast-Enhanced Abdominal CT:Comparison of Photon-Counting Detector CT with 2nd Generation Dual-Source Dual-Energy CT in an oncologic cohort. Acad Radiol 2023;30:855-862
6) Jungblut L, Euler A, von Spiczak J, et al:Potential of Photon-Counting Detector CT for Radiation Dose Re-duction for the Assessment of Interstitial Lung Disease in Patients With Systemic Sclerosis. Invest Radiol 2022;57:773-779
7) Niehoff JH, Carmichael AF, Woeltjen MM, et al:Clinical Low Dose Photon Counting CT for the Detection of Urolithiasis:Evaluation of Image Quality and Radiation Dose. Tomography 2022;8:1666-1675
8) van der Werf NR, van Gent M, Booij R, et al:Dose Reduction in Coronary Artery Calcium Scoring Using Mono-Energetic Images from Reduced Tube Voltage Dual-Source Photon-Counting CT Data:A Dynamic Phantom Study. Diagnostics(Basel) 2021;11:2192
9) Grunz JP, Petritsch B, Luetkens KS, et al:Ultra-Low-Dose Photon-Counting CT Imaging of the Paranasal Sinus With Tin Prefiltration:How Low Can We Go? Invest Radiol 2022;57:728-733
10) Rajendran K, Petersilka M, Henning A, et al:First Clinical Photon-counting Detector CT System:Technical Evaluation. Radiology 2022;303:130-138
11) Kalisz K, Buethe J, Saboo SS, et al:Artifacts at Cardiac CT:Physics and Solutions. Radiographics 2016;36:2064-2083
12) Allmendinger T, Nowak T, Flohr T, et al:Photon-Counting Detector CT-Based Vascular Calcium Removal Algorithm:Assessment Using a Cardiac Motion Phantom. Invest Radiol 2022;57:399-405
13) Yu L, Leng S, McCollough CH:Dual-energy CT-based monochromatic imaging. AJR Am J Roentgenol 2012;199(5 Suppl):S9-S15
14) McCollough CH, Boedeker K, Cody D, et al:Principles and applications of multienergy CT:Report of AAPM Task Group 291. Med Phys 2020;47:e881-e912
15) Berger MJ, Hubbell JH, Seltzer SM, et al:XCOM:Photon Cross Sections Database, NIST Standard Reference Database 8(XGAM). Last update 2010. https://www.nist.gov/pml/xcom-photon-cross-sectionsdatabase(cited 2024 Feb 15)
16) Thieme SF, Becker CR, Hacker M, et al:Dual energy CT for the assessment of lung perfusion--correlation to scintigraphy. Eur J Radiol 2008;68:369-374
17) Sakabe D, Funama Y, Taguchi K, et al:Image quality characteristics for virtual monoenergetic images using dual-layer spectral detector CT:Comparison with conventional tube-voltage images. Phys Med 2018;49:5-10
18) Altenbernd J, Heusner TA, Ringelstein A, et al:Dualenergy-CT of hypervascular liver lesions in patients with HCC:investigation of image quality and sensitivity. Eur Radiol 2011;21:738-743
19) Nagayama Y, Nakaura T, Oda S, et al:Dual-layer DECT for multiphasic hepatic CT with 50 percent iodine load:a matched-pair comparison with a 120 kVp protocol. Eur Radiol 2018;28:1719-1730
20) Johnson TR, Krauss B, Sedlmair M, et al:Material differentiation by dual energy CT:initial experience. Eur Radiol 2007;17:1510-1517
21) Sodickson AD, Keraliya A, Czakowski B, et al:Dual energy CT in clinical routine:how it works and how it adds value. Emerg Radiol 2021;28:103-117
P.334 掲載の参考文献
1) van der Werf NR, Booij R, Greuter MJW, et al:Reproducibility of coronary artery calcium quantification on dual-source CT and dual-source photon-counting CT:a dynamic phantom study. Int J Cardiovasc Imaging 2022;38:1613-1619
2) Dobrolinska MM, van der Werf NR, van der Bie J, et al:Radiation dose optimization for photon-counting CT coronary artery calcium scoring for different patient sizes:a dynamic phantom study. Eur Radiol 2023;33:4668-4675
3) Xie C, Chan K, Nikolaidou C, et al:Photon counting computed tomography:pure calcium using coronary computed tomography angiography vs calcium mea-surement from non-contrast computed tomography. J Cardiovasc Comput Tomogr 2023;17(Suppl 4):S75
4) Rajendran K, Petersilka M, Henning A, et al:First clinical photon-counting detector CT system:technical evaluation. Radiology 2022;303:130-138
5) Si-Mohamed SA, Boccalini S, Lacombe H, et al:Coronary CT Angiography with Photon-counting CT:First-In-Human Results. Radiology 2022;303:303-313
6) McCollough CH, Rajiah P, Bois JP, et al:Comparison of Photon-counting Detector and Energy-integrating Detector CT for Visual Estimation of Coronary Percent Luminal Stenosis. Radiology 2023;309:e230853
7) Hagar MT, Soschynski M, Saffar R, et al:Accuracy of Ultrahigh-Resolution Photon-counting CT for Detecting Coronary Artery Disease in a High-Risk Population. Radiology 2023;307:e223305
8) Mergen V, Sartoretti T, Baer-Beck M, et al:Ultra-High-Resolution Coronary CT Angiography With Photon-Counting Detector CT:Feasibility and Image Characterization. Invest Radial 2022;57:780-788
9) Decker JA, O'Doherty J, Schoepf UJ, et al:Stent imaging on a clinical dual-source photon-counting detector CT system-impact of luminal attenuation and sharp kernels on lumen visibility. Eur Radial 2023;33:2469-2477
10) Mergen V, Eberhard M, Manka R, et al:First in-human quantitative plaque characterization with ultra-high resolution coronary photon-counting CT angiography. Front Cardiovasc Med 2022;9:981012
11) Allmendinger T, Nowak T, Flohr T, et al:Photoncounting detector CT-based vascular calcium removal algorithm:assessment using a cardiac motion phantom. Invest Radiol 2022;57:399-405
12) Nishihara T, Miyoshi T, Nakashima M, et al:Diagnostic improvements of calcium-removal image reconstruction algorithm using photon-counting detector CT for calcified coronary lesions. Eur J Radiol 2024;172:111354
13) Cundari G, Deilmann P, Mergen V, et al:Saving contrast media in coronary CT angiography with photoncounting detector CT. Acad Radiol 2024;31:212-220
P.344 掲載の参考文献
1) 宿谷 篤, 橋本慎也, 山崎隆広, ほか:2 層検出器搭載 128列/256 スライススペクトラルCTの有用性と可能性. Innervision 2023;38:14-18
2) 粟井和夫, 檜垣 徹:Dual-energy CTの基本アプリケーション. 粟井和夫・編:Dual-energy CT原理を理解し臨床で活用する. 東京:メジカルビュー;2019. p.32-44
3) Matsui K, Machida H, Mitsuhashi T, et al:Analysis of coronary arterial calcification components with coronary CT angiography using single-source dual-energy CT with fast tube voltage switching. Int J Cardiovasc Imaging 2015;31:639-647
4) Nakajima S, Ito H, Mitsuhashi T, et al:Clinical application of effective atomic number for classifying non-calcified coronary plaques by dual-energy computed tomography. Atherosclerosis 2017;261:138-143
5) Kaichi Y, Tatsugami F, Nakamura Y, et al:Improved differentiation between high-and low-grade gliomas by combining dual-energy CT analysis and perfusion CT. Medicine(Baltimore) 2018;97:e11670.
6) Mazurek T, Zhang L, Zalewski A, et al:Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003;108:2460-2466
7) Tanaka K, Sata M:Possible roles of epicardial adipose tissue in the pathogenesis of coronary atherosclerosis. Ann Nucl Cardiol 2018;4:5-10
8) West HW, Siddique M, Williams MC;ORFAN Investigators:Deep-Learning for Epicardial Adipose Tissue Assessment With Computed Tomography:Implications for Cardiovascular Risk Prediction. JACC Cardiovasc Imaging 2023;16:800-816
9) Liu J, Fan W, Liu Y, et al:Association of Epicardial and Pericardial Adipose Tissue Volumes with Coronary Artery Calcification. Int Heart J 2022;63:1019-1025
10) 船橋伸禎, 宿谷 篤, 三角和雄:2 層検出器をもつスペクトラルCTが臨床にもたらすインパクト. 医学のあゆみ2023;287:529-532
P.356 掲載の参考文献
1) Masuda Y, Yoshida H, Morooka N, et al:The usefulness of x-ray computed tomography for the diagnosis of myocardial infarction. Circulation 1984;70:217-225
2) Takaoka H, Funabashi N, Ozawa K, et al:Improved Diagnosis of Detection of Late Enhancement in Left Ventricular Myocardium Using 2nd Generation 320-Slice CT Reconstructed with FIRST in Non-Ischemic Cardiomyopathy. Int Heart J 2018;59:542-549
3) Kim RJ, Fieno DS, Parrish TB, et al:Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002
4) Kim RJ, Wu E, Rafael A, et al:The use of contrastenhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-1453
5) 宿谷 篤, 橋本慎也, 山崎隆広, ほか:2 層検出器搭載 128列/256 スライススペクトラルCTの有用性と可能性. Innervision 2023;38:14-18
6) 船橋伸禎, 宿谷 篤, 三角和雄:2 層検出器をもつスペクトラルCTが臨床にもたらすインパクト. 医学のあゆみ2023;287:529-532
7) 粟井和夫, 檜垣 徹:Dual-energy CTの基本アプリケーション. 粟井和夫・編:Dual-energy CT原理を理解し臨床で活用する. 東京:メジカルビュー;2019. p.32-44
8) Beppu S, Izumi S, Miyatake K, et al:Abnormal blood pathways in left ventricular cavity in acute myocardial infarction. Experimental observations with special reference to regional wall motion abnormality and hemo-stasis. Circulation 1988;78:157-164
9) Oda S, Emoto T, Nakaura T, et al:Myocardial Late Iodine Enhancement and Extracellular Volume Quantification with Dual-Layer Spectral Detector Dual-Energy Cardiac CT. Radial Cardiothorac Imaging 2019;1:e180003
10) Emoto T, Oda S, Kidoh M, et al:Myocardial Extracellular Volume Quantification Using Cardiac Computed Tomography:A Comparison of the Dual-energy Iodine Method and the Standard Subtraction Method. Acad Radial 2021;28:e119-e126
P.364 掲載の参考文献
1) 一般社団法人 日本痛風・尿酸核酸学会 ガイドライン改訂委員会・編:高尿酸血症・痛風の治療ガイドライン 第3版. 東京:診断と治療社;2018.
2) McCollough CH, Leng S, Yu L, Fletcher JG:Dual-and Multi-Energy CT:Principles, Technical Approaches, and Clinical Applications. Radiology 2015;276:637-653
3) 町田治彦, 竹内 均, 田中 功, ほか:痛風のためのdual-energy CTの現状. 高尿酸血症と痛風2015;23:62-67
4) 町田治彦, 田中 功, 福井利佳, ほか:痛風のためのdual-energy CTの基本原理と臨床応用. 高尿酸血症と痛風2013;21:149-155
5) 町田治彦, 竹内 均, 田中 功, ほか:【Dual energy CTの現状と展望-次世代の標準的CT に向けて-】骨軟部. 臨床画像2015;31:498-507
6) 町田治彦, 谷口敦夫, 石川拓也, 上野惠子:【高尿酸血症・低尿酸血症-最近の診断と治療-】高尿酸血症の臨床 高尿酸血症・痛風の検査・診断・治療 検査・診断 Dual-energy CT. 日本臨牀2016:74(増刊号9):188-192
7) Choi HK, Burns LC, Shojania K, et al:Dual energy CT in gout:a prospective validation study. Ann Rheum Dis 2012;71:1466-1471
8) Gerster JC, Landry M, Dufresne L, Meuwly JY:Imaging of tophaceous gout:computed tomography provides specific images compared with magnetic resonance imaging and ultrasonography. Ann Rheum Dis 2002;61:52-54
9) Neogi T, Jansen TL, Dalbeth N, et al:2015 Gout classification criteria:an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2015;74:1789-1798
10) Mallinson PI, Coupal T, Reisinger C, et al:Artifacts in dual-energy CT gout protocol:a review of 50 suspected cases with an artifact identification guide. AJR Am J Roentgenol 2014;203:W103-109
11) Ogdie A, Taylor WJ, Weatherall M, et al:Imaging modalities for the classification of gout:systematic literature review and meta-analysis. Ann Rheum Dis 2015;74:1868-1874
12) Yu Z, Mao T, Xu Y, et al:Diagnostic accuracy of dualenergy CT in gout:a systematic review and metaanalysis. Skeletal Radiol 2018;47:1587-1593
13) Gamala M, Jacobs JWG, van Laar JM:The diagnostic performance of dual energy CT for diagnosing gout:a systematic literature review and meta-analysis. Rheumatology(Oxford) 2019;58:2117-2121
14) Shang J, Zhou LP, Wang H, Liu B:Diagnostic Performance of Dual-energy CT Versus Ultrasonography in Gout:A Meta-analysis. Acad Radiol 2022;29:56-68
15) Lee KA, Ryu SR, Park SJ, et al:Assessment of cardiovascular risk profile based on measurement of tophus volume in patients with gout. Clin Rheumatol 2018;37:1351-1358
16) Stauder SK, Peloso PM:Dual-Energy Computed Tomography Has Additional Prognostic Value Over Clinical Measures in Gout Including Tophi:A Systematic Literature Review. J Rheumatol 2022;49:1256-1268
17) 町田治彦, 西川真木子, 苅安俊哉, ほか:最新CT技術の臨床応用 -超高精細CTとスペクトラルCTの臨床的有用性-. 杏林医学会雑誌2021;52:123-132
18) Klauser AS, Halpern EJ, Strobl S, et al:Dual-Energy Computed Tomography Detection of Cardiovascular Monosodium Urate Deposits in Patients With Gout. JAMA Cardiol 2019;4:1019-1028
19) Khanna I, Pietro R, Ali Y:What Has Dual Energy CT Taught Us About Gout? Curr Rheumatol Rep 2021;23:71

【連載】

P.367 掲載の参考文献
1) Maurer MS, Schwartz JH, Gundapaneni B, et al:Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy. N Engl J Med 2018;379(11):1007-1016
2) Adams D, Gonzalez-Duarte A, O'Riordan WD, et al:Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis. N Engl J Med 2018;379(1):11-21
3) Alnylam Pharmaceuticals:APOLLO-B, a Study of Patisiran in Patients With Transthyretin Cardiac Amyloidosis:Primary Long-Term Results From the Open-Label Extension Period[updated 2023-11-13]. Available from:https://capella.alnylam.com/2023/11/13/pati-aha-2023(last accessed 3/3/2024)

【HEART' s Original】

P.375 掲載の参考文献
2) Ford C, Xie CX, Low A, et al:Comparison of 2 Smart Watch Algorithms for Detection of Atrial Fibrillation and the Benefit of Clinician Interpretation:SMART WARS Study. JACC Clin Electrophysiol 2022;8:782-791
3) Samol A, Bischof K, Luani B, et al:Recording of Bipolar Multichannel ECGs by a Smartwatch:Modern ECG Diagnostic 100 Years after Einthoven. Sensors(Basel)2019;19:2894
4) Avila CO:Novel Use of Apple Watch 4 to Obtain 3-Lead Electrocardiogram and Detect Cardiac Ischemia. Perm J 2019;23:19-25
6) van der Zande J, Strik M, Dubois R, et al:Using a Smartwatch to Record Precordial Electrocardiograms:A Validation Study. Sensors(Basel) 2023;23:2555
7) Li K, Elgalad A, Cardoso C, Perin EC:Using the Apple Watch to Record Multiple-Lead Electrocardiograms in Detecting Myocardial Infarction:Where Are We Now? Tex Heart Inst J 2022;49:e227845
8) Spaccarotella CAM, Migliarino S, Mongiardo A, et al:Measurement of the QT interval using the Apple Watch. Sci Rep 2021;11:10817
9) Apple:添付文書を含む使用説明(IFU). https://www.apple.com/legal/ifu/ecg/Apple-Japan-Instructionsfor-Use(-IFU)-ECG-App-1.0.pdf(cited 2023 Jul 05)
10) 厚生労働省 医療機器・再生医療等製品安全対策部会:「家庭用心電計プログラム」及び「家庭用心拍数モニタプログラム」の適正使用について(薬生機審発0127第7号/薬生安発0127第4号 令和3年1月27日). https://www.mhlw.go.jp/content/11121000/000757908.pdf(cited 2023 Jul 05)
P.376 掲載の参考文献
1) 日本循環器学会/日本不整脈心電学会:2022年改訂版 不整脈の診断とリスク評価に関するガイドライン. https://www.j-circ.or.jp/cms/wp-content/uploads/2022/03/JCS2022_Takase.pdf(Cited 2024Mar 10)
2) Bumgarner JM, Lambert CT, Hussein AA, et al:Smartwatch algorithm for automated detection of atrial fibrillation. J Am Coll Cardiol 2018;71:2381-2388
3) Perez MV, Mahaffey KW, Hedlin H, et al;Apple Heart Study Investigators:Large-scale assessment of a smartwatch to identify atrial fibrillation. N Engl J Med 2019;381:1909-1917
4) Cobos Gil MA:Standard and precordial leads obtained with an Apple Watch. Ann Intern Med 2020;172:436-437
5) Samol A, Bischof K, Luani B, et al:Single-lead ECG recordings including Einthoven and Wilson leads by a smartwatch:A new era of patient directed early ECG differential diagnosis of cardiac diseases? Sensors(Basel) 2019;19:4377
P.383 掲載の参考文献
1) Mehall JR, Shroff S, Fassler SA, et al:Comparing results of residents and attending surgeons to determine whether laparoscopic colectomy is safe. Am J Surg 2005;189:738-741
2) 森下清文, 馬場俊雄, 大堀俊介, ほか:ハイリスク患者を含めて腹部大動脈ステントグラフトを研修医は安全に手術できるか?日血外会誌 2012;21:721-724
3) Lee KS, Natarajan B, Wong WX, et al:A randomized controlled trial of simulation training in teaching coronary angiographic views. BMC Med Educ 2022;22:644
4) Casey DB, Stewart D, Vidovich MI:Diagnotic coronary angiography:initial results of a simulation program. Cardiovasc Revasc Med 2016;17:102-105
5) Bagai A, O'Brien S, Al Lawati H, et al:Mentored simulation training improves procedural skills in cardiac catheterization.:a randomized, controlled pilot study. Circ Cardiovasc Interv 2012;5:672-679
6) Popovic B, Pinelli S, Albuisson E, et al:The simulation training in coronary angiography and its impact on real life conduct in the catheterization laboratory. Am J Cardiol 2019;123:1208-1213
7) Green SM, Klein AJ, Pancholy S, et al:The current state of medical simulation in interventional cardiology:a clinical document from the society for cardiovascular angiography and intervention's(SCAI) simulation committee. Catheter Cardiovasc Interv 2014;83:37-46
8) 成島道昭, 世良田和幸:シミュレーション教育を用いた昭和大学横浜市北部病院における中心静脈カテーテル挿入に関するシステムの構築. 昭和学士会誌 2013;73:512-517
9) 坂井美紀子, 森 美香, 高田龍也, ほか:当院におけるエコーガイド下穿刺への取り組み. 大阪透析研会誌 2022;39:41-44
P.390 掲載の参考文献
1) Otto CM, Nishimura RA, Bonow RO, et al:2020 ACC/AHA Guideline for the management of patients with valvular heart disease:Executive summary:A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 2021;77:450-500
2) Vahanian A, Beyersdorf F, Praz F, et al:2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2022;43:561-632
3) Keeble TR, Khokhar A, Akhtar MM, et al:Percutaneous balloon aortic valvuloplasty in the era of transcatheter aortic valve implantation:a narrative review. Open Heart 2016;3:e000421
4) Mckay RG:The Mansfield Scientific Aortic Valvuloplasty Registry:overview of acute hemodynamic results and procedural complications. J Am Coll Cardiol 1991;17:485-491
5) Chiang M, Gonzalez PE, O'Neill BP, et al:Left Atrial Venoarterial Extracorporeal Membrane Oxygenation for Acute Aortic Regurgitation and Cardiogenic Shock. JACC Case Rep 2022;4:276-279
6) 日本循環器学会:2021年改訂版 循環器超音波検査の適応と判読ガイドライン. https://www.j-circ.or.jp/cms/wp-content/uploads/2021/03/JCS2021_Ohte.pdf(cited2023 Oct 03)
7) Loncar S, Perlman G, Planer D, et al:Acute aortic regurgitation and hemodynamic collapse after balloon aortic valvuloplasty. Int J Cardiol 2014;171:88-89
8) Maldonado Y, Baisden J, Villablanca PA, et al:General Anesthesia Versus Conscious Sedation for Transcatheter Aortic Valve Replacement-An Analysis of Current Outcome Date. J Cardiothorac Vasc Anesth 2018;32:1081-1086
P.396 掲載の参考文献
1) Schwaiblmair M, Berghaus T, Haeckel T, et al:Amiodarone-induced pulmonary toxicity:an under-recognized and severe adverse effect? Clin Res Cardiol 2010;99:693-700
2) Goldstein I, Topilsky M, Segev D, et al:Very easy onset of acute amiodarone pulmonary toxicity presenting with hemoptysis. Chest 1997;111:1446-1447
3) Vorperian VR, Havighurst TC, Miller S, January CT:Adverse effects of low dose amiodarone:a meta-analysis. J Am Coll Cardiol 1997;30:791-798
4) Ott MC, Khoor A, Leventhal JP, et al:Pulmonary toxicity in patients receiving low-dose amiodarone. Chest 2003;123:646-651
5) 細谷真紀, 八木卓也, 戸田 直, ほか:アミオダロン投与後早期に発症した肺出血に対しステロイドパルス療法が奏効した1例. Prog Med 2005;25(suppl-1):1547-1551
6) 長崎 彩, 小林謙太郎:アミオダロンによる肺障害の1例. 気管支学 2019;41:205
7) 前川邦彦, 奈良 理, 俵 敏弘, ほか:ECPRによる蘇生後に肺胞出血を合併した1例. 日集中医誌 2009;16(suppl):277
8) 佐竹有貴, 鈴木 敦, 鈴木 豪, ほか:アミオダロン投与5カ月後に肺胞出血を来たした1例. 東女医大誌 2014;84:32
9) 久保田翔太, 嶋田貴文, 松村聡介, ほか:アミオダロンによる肺胞出血を伴った薬剤性肺障害の1例. 茨城臨医誌 2020;55:16
10) Martin WJ 2nd, Rosenow EC 3rd:Amiodarone pulmonary toxicity. Recognition and pathogenesis(Part 1). Chest 1988;93:1067-1075
11) 立石和也, 金子雅一, 宮坂政紀, ほか:アミオダロンによる肺胞出血にて死亡した急性僧房弁閉鎖不全症の1例. 第589回 日本内科学会関東地方会. 2012/7/15;東京
12) Adverse Drug Reactions Advisory Committee. The multiple toxicities of amiodarone. Aust Adv Drug React Bull 2005;24:11
13) Adams GD, Kehoe R, Lesch M, Glassroth J:Amiodarone-induced pneumonitis. Assessment of risk factors and possible risk reduction. Chest 1988;93:254-263
P.397 掲載の参考文献
1) Ono K, Iwasaki YK, Akao M, et al:JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias. Circ J 2022;86:1790-1924
2) Yamada Y, Shiga T, Matsuda N, et al:Incidence and predictors of pulmonary toxicity in Japanese patients receiving low-dose amiodarone. Circ J 2007;71:1610-1616
3) Schwaiblmair M, Berghaus T, Haeckel T, et al:Amiodarone-induced pulmonary toxicity:an under-recognized and severe adverse effect? Clin Res Cardiol 2010;99:693-700
4) Pitcher WD:Amiodarone pulmonary toxicity. Am J Med Sci 1992;303:206-212
P.403 掲載の参考文献
1) Bettinelli A, Tosetto C, Colussi G, et al:Electrocardiogram with prolonged QT interval in Gitelman disease. Kidney Int 2002;62:580-584
2) 中村牧子, 上野博志, 中垣内昌樹, ほか:VF 心肺停止でECMO+IMPELLA による循環補助とPCIを行い救命した1例. 心臓2019;51:611-618
3) Pappalardo F, Schulte C, Pieri M, et al:Concomitant implantation of Impella(R) on top of veno-arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock. Eur J Heart Fail 2017;19:404-412
4) Shibasaki I, Masawa T, Abe S, et al:Benefit of venoarterial extracorporeal membrane oxygenation combined with Impella(ECpella) therapy in acute coronary syndrome with cardiogenic shock. J Cardiol 2022;80:116-124
5) 日本中毒学会:『消化管除染(1)胃洗浄』. http://jsctweb.umin.jp/shiryou/standardtreatment/(cited 2023 May 20)
6) 加藤規利:急性薬物中毒患者への緊急透析・血漿交換. medicina 2019;56:1382-1385
P.410 掲載の参考文献
1) 坂爪 公, 齋木佳克:人工循環中の出血凝固因子. 人工臓器 2016;45:221-224
2) Weber CF, Gorlinger K, Meininger D, et al:Point-of-care testing:a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 2012;117:531-547
3) Serraino GF, Murphy GJ:Routine use of viscoelastic blood tests for diagnosis and treatment of coagulopathic bleeding in cardiac surgery:updated systematic review and meta-analysis. Br J Anaesth 2017;118:823-833
4) 坂田飛鳥, 大森 司:Tissue factor pathway inhibitor(TFPI)の基礎. 血栓止血誌 2014;25:5-10
5) 香取信之:心臓血管手術におけるリコンビナント活性型第VII因子製剤(ノボセブン(R))の適応-CON. Cardiovascular Anesthesia 2011;15:119-125
6) 宮田茂樹, 板倉敦夫, 上田裕一, ほか:大量出血症例に対する血液製剤の適正な使用のガイドライン. 日輸血細胞治療会誌 2019;65:21-91
7) Tomita E, Takase H, Tajima K, Suematsu Y:Change of coagulation after NovoSeven(R) use for bleeding during cardiac surgery. Asian Cardiovasc Thorac Ann 2017;25:99-104
8) Ise H, Ushioda R, Kanda H, et al:Recombinant Activated Factor VII in Aortic Surgery for Patients Under Hypothermic Circulatory Arrest. Ther Clin Risk Manag 2022;18:337-348
9) Feih JT, Juul JJ, Rinka JRG, et al:Adequacy of hemostatic resuscitation improves therapeutic efficacy of recombinant activated factor VII and reduces reexploration rate for bleeding in postoperative cardiac surgery patients with refractory hemorrhage. Ann Card Anaesth 2019;22:388-393
10) Zindovic I, Sjogren J, Ahlsson A, et al:Recombinant factor VIIa use in acute type A aortic dissection repair:A multicenter propensity-score-matched report from the Nordic Consortium for Acute Type A Aortic Dissection. J Thorac Cardiovasc Surg 2017;154:1852-1859
11) Alfirevic A, Duncan A, You J, et al:Recombinant factor VII is associated with worse survival in complex cardiac surgical patients. Ann Thorac Surg 2014;98:618-624
P.413 掲載の参考文献
1) 松下 正:凝固障害に対する補充療法-標準的治療法の整理. 日輸血細胞治療会誌 2013;59:571-578
2) Gill R, Herbertson M, Vuylsteke A, et al:Safety and efficacy of recombinant activated factor VII:a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. Circulation 2009;120:21-27

最近チェックした商品履歴

Loading...